1型糖尿病、衰老与衰弱:一个尚未充分探索的交叉领域
本文综述了1型糖尿病(T1D)患者寿命延长背景下衰弱这一老年综合征的研究进展。文章指出,T1D可能通过持续高血糖和反复低血糖加速衰老,而衰弱与低血糖、住院、残疾、机构化和死亡风险增加相关;目前相关文献多集中于2型糖尿病,T1D与衰弱的关系及对结局的影响仍待阐明。
要点
- T1D患者寿命改善的同时,衰弱等老年综合征成为新的管理挑战。
- 衰弱与低血糖、住院、残疾、机构化和死亡等不良结局相关。
- T1D衰弱的病理生理涉及高血糖、血管并发症、激素变化、肌少症和认知下降等多因素。
核心结论
- T1D可能通过持续高血糖和反复低血糖加速衰老并促发衰弱,但T1D与衰弱的关系及其对结局的影响尚未完全阐明。
研究设计与样本
- 综述类文章,围绕T1D与衰弱的关联、病理生理机制、评估与治疗策略及研究空白进行讨论。
主要发现
- 近几十年来,由于代谢控制改善及并发症防治进步,T1D患者预期寿命稳步提高。
- 衰弱被定义为生理储备下降、对应激源易感性增加且急性事件后恢复稳态能力受损的状态。
- 衰弱已被视为糖尿病的并发症之一,并与低血糖、住院、残疾、机构化和死亡风险增加相关。
- T1D衰弱的病理生理复杂多因素,包括慢性高血糖直接效应及微血管和大血管并发症,叠加年龄和糖尿病相关激素变化,肌少症、认知下降和其他合并症亦有贡献。
- 目前多数糖尿病与衰弱文献聚焦于2型糖尿病。
临床怎么用
- 在内分泌科随访中应关注T1D患者(尤其随年龄增长)的衰弱风险评估与识别。
- 对存在衰弱的T1D患者需加强低血糖防范及综合并发症管理。
局限性
- T1D与衰弱关系及结局影响的研究证据仍有限,多数文献来自2型糖尿病。
- 文中指出该领域存在关键知识空白,需未来研究进一步明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over recent decades, the life expectancy of individuals with type 1 diabetes has steadily improved due to advances in therapies that enhance metabolic control alongside better prevention and management of complications. However, this extended survival brings new challenges. Type 1 diabetes, through sustained hyperglycaemia and recurrent hypoglycaemia, may act as an accelerator of ageing, predisposing individuals to the development of geriatric syndromes such as frailty. Frailty, defined as a state of reduced physiological reserve that heightens susceptibility to stressors and impairs the ability to restore homeostasis after acute events, has emerged as a recognised complication of diabetes and has been associated with several adverse outcomes including increased risks of hypoglycaemia, hospitalisation, disability, institutionalisation and death. The putative pathophysiology of frailty in type 1 diabetes is complex and multifactorial. It reflects the direct effects of chronic exposure to hyperglycaemia and consequent micro- and macrovascular complications, superimposed on age- and diabetes-related hormonal changes. Additional contributors include sarcopenia, cognitive decline and other comorbidities. Currently, most of the literature on diabetes and frailty focuses on type 2 diabetes, while the relationship with type 1 diabetes and the impact on outcomes remain to be fully elucidated. In this review we discuss the growing evidence on the link between frailty and type 1 diabetes, explore its underlying pathophysiological mechanisms, discuss assessment and treatment strategies, and highlight the key knowledge gaps and suggest future research directions in this evolving field.
引用
- Maltese G, Karalliedde J, Dhesi J, et al. Type 1 diabetes, ageing and frailty: an underexplored intersection. Diabetologia. 2026. PMID: 41701264. doi:10.1007/s00125-026-06681-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。